PROVIDER PROFILE · NPI 1306262217
Amy RyanMSN, CRNP
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
175
Unique beneficiaries
—
Total services
306
Distinct HCPCS
3
Medicare payment
$22K
Peer benchmark
Total Medicare services vs. 4,258 Nurse Practitioner providers in MD — below median (cohort median 389).
PRESCRIBING · PART D · 2024
Total Rx claims
555
Beneficiaries
—
Total drug cost
$157K
Distinct drugs
14
Brand share
37.8%
Top prescribed drugs
Oxycodone Hcl104 claims
Ondansetron Hcl68 claims
Morphine Sulfate64 claims
Apixaban60 claims
Lipase/Protease/Amylase43 claims
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Amy Ryan's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 7 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Elliot Fishman Diagnostic Radiology · Baltimore, MD | 60 | 164 |
| Daniel Laheru Medical Oncology · Baltimore, MD | 35 | 330 |
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 18 | 67 |
| Johns Hopkins University Clinical Laboratory · Baltimore, MD | 12 | 22 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| THE JOHNS HOPKINS HOSPITAL | 95 | 726 |
| Daniel Laheru Medical Oncology · Baltimore, MD | 42 | 321 |
| Elliot Fishman Diagnostic Radiology · Baltimore, MD | 26 | 64 |
| Nilofer Azad Hematology-Oncology · Baltimore, MD | 23 | 262 |
| BLEICH, KAREN | 16 | 64 |
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 14 | 43 |
| HERMAN, JOSEPH | 12 | 64 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE